Philippe Selhorst
Philippe Selhorst
Verified email at itg.be
Title
Cited by
Cited by
Year
Global and regional molecular epidemiology of HIV-1, 1990–2015: a systematic review, global survey, and trend analysis
J Hemelaar, R Elangovan, J Yun, L Dickson-Tetteh, I Fleminger, S Kirtley, ...
The Lancet infectious diseases 19 (2), 143-155, 2019
1442019
Integrin α4β7 expression on peripheral blood CD4+ T cells predicts HIV acquisition and disease progression outcomes
A Sivro, A Schuetz, D Sheward, V Joag, S Yegorov, LJ Liebenberg, ...
Science translational medicine 10 (425), 2018
762018
The HIV-1 transmission bottleneck
SM Kariuki, P Selhorst, KK AriŽn, JR Dorfman
Retrovirology 14 (1), 1-19, 2017
642017
Symptomatic SARS-CoV-2 re-infection of a health care worker in a Belgian nosocomial outbreak despite primary neutralizing antibody response.
P Selhorst, S Van Ierssel, J Michiels, J MariŽn, K Bartholomeeusen, ...
MedRxiv, 2020
482020
Cervicovaginal inflammation facilitates acquisition of less infectious HIV variants
P Selhorst, L Masson, SD Ismail, N Samsunder, N Garrett, LE Mansoor, ...
Clinical Infectious Diseases 64 (1), 79-82, 2017
392017
Cooperation between strain-specific and broadly neutralizing responses limited viral escape and prolonged the exposure of the broadly neutralizing epitope
C Anthony, T York, V Bekker, D Matten, P Selhorst, RC Ferreria, ...
Journal of virology 91 (18), e00828-17, 2017
372017
Human immunodeficiency virus type 1 resistance or cross-resistance to nonnucleoside reverse transcriptase inhibitors currently under development as microbicides
P Selhorst, AC Vazquez, K Terrazas-Aranda, J Michiels, K Vereecken, ...
Antimicrobial agents and chemotherapy 55 (4), 1403-1413, 2011
372011
MiniCD4 protein resistance mutations affect binding to the HIV-1 gp120 CD4 binding site and decrease entry efficiency
K Grupping, P Selhorst, J Michiels, K Vereecken, L Heyndrickx, P Kessler, ...
Retrovirology 9 (1), 1-16, 2012
222012
Inhibition of HIV-1 by non-nucleoside reverse transcriptase inhibitors via an induced fit mechanism—importance of slow dissociation and relaxation rates for antiviral efficacy
M Elinder, P Selhorst, G Vanham, B ÷berg, L Vrang, UH Danielson
Biochemical pharmacology 80 (8), 1133-1140, 2010
222010
Longer-term outcomes of HIV-positive–to–HIV-positive renal transplantation
P Selhorst, CE Combrinck, K Manning, FCJ Botha, JPL Labuschagne, ...
New England Journal of Medicine 381 (14), 1387-1389, 2019
212019
Case report: mechanisms of HIV elite control in two African women
Y Moosa, RF Tanko, V Ramsuran, R Singh, M Madzivhandila, ...
BMC infectious diseases 18 (1), 1-7, 2018
182018
Replication capacity of viruses from acute infection drives HIV-1 disease progression
P Selhorst, C Combrinck, N Ndabambi, SD Ismail, MR Abrahams, ...
Journal of virology 91 (8), e01806-16, 2017
152017
M48U1 CD4 mimetic has a sustained inhibitory effect on cell-associated HIV-1 by attenuating virion infectivity through gp120 shedding
P Selhorst, K Grupping, T Tong, ET Crooks, L Martin, G Vanham, ...
Retrovirology 10 (1), 1-9, 2013
142013
In Vitro Activities of Candidate Microbicides against Cell-Associated HIV
P Selhorst, K Grupping, T Bourlet, O Delťzay, KK AriŽn, G Vanham
Antimicrobial agents and chemotherapy 56 (2), 805-815, 2012
132012
Global and regional epidemiology of HIV-1 recombinants in 1990–2015: A systematic review and global survey
J Hemelaar, R Elangovan, J Yun, L Dickson-Tetteh, S Kirtley, ...
The Lancet HIV 7 (11), e772-e781, 2020
92020
Study of a SARS-CoV-2 outbreak in a Belgian military education and training center in Maradi, Niger
JP Pirnay, P Selhorst, C Cochez, M Petrillo, V Claes, Y Van der Beken, ...
Viruses 12 (9), 949, 2020
92020
Detectable HIV-1 in semen in individuals with very low blood viral loads
SM Kariuki, P Selhorst, J Norman, K Cohen, K Rebe, C Williamson, ...
Virology journal 17 (1), 1-5, 2020
62020
Rational design of HIV vaccine and microbicides: report of the EUROPRISE annual conference
B Wahren, P Biswas, M Borggren, A Coleman, K Da Costa, W De Haes, ...
Journal of translational medicine 8 (1), 1-11, 2010
62010
Rational design of HIV vaccine and microbicides: report of the EUROPRISE annual conference
B Wahren, P Biswas, M Borggren, A Coleman, K Da Costa, W De Haes, ...
Journal of translational medicine 8 (1), 1-11, 2010
62010
CAPRISA004 and RV254 study groups
A Sivro, A Schuetz, D Sheward, V Joag, S Yegorov, LJ Liebenberg, ...
Integrin α 4, 0
6
The system can't perform the operation now. Try again later.
Articles 1–20